The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls

Behavior Genetics

Volumn 40, Issue 1, 2010, Pages 49-58

  Clague, Jessica ^a   Cinciripini, Paul ^a   Blalock, Janice ^a   Wu, Xifeng ^a   Hudmon, Karen S ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Bladder cancer; DRD2; Nicotine dependence

Indexed keywords

DOPAMINE 2 RECEPTOR; NICOTINE;

ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER PATIENT; CIGARETTE SMOKING; CONTROLLED STUDY; DOPAMINE 2 RECEPTOR GENE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RECEPTOR GENE; SMOKING CESSATION; TOBACCO; TOBACCO DEPENDENCE;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; SEQUENCE ANALYSIS, DNA; SMOKING; TOBACCO USE DISORDER; URINARY BLADDER NEOPLASMS;

NICOTIANA TABACUM;

EID: 77949292298     PISSN: 00018244     EISSN: 15733297     Source Type: Journal    
DOI: 10.1007/s10519-009-9301-0     Document Type: Article

References (39)

1. Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG (2004a) Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry 161(7):1224-1230
2. Audrain-McGovern J, Rodriguez D, Tercyak KP, Epstein LH, Goldman P, Wileyto EP (2004b) Applying a behavioral economic framework to understanding adolescent smoking. Psychol Addict Behav 18(1):64-73
3. Batra VPA, Berrettini WH, Weinstein SP, Leone FT (2003) The genetic determinants of smoking. Chest 123(5):1730-1739
4. Benowitz NL (1992) Cigarette smoking and nicotine addiction. Med Clin North Am 76(2):415-437
5. Benowitz NL (1999) The biology of nicotine dependence: from the z1988 Surgeon General's Report to the present and into the future. Nicotine Tob Res 1(Suppl 2):S159-S163
6. Bierut LJ, Rice JP, Edenberg HJ, Goate A, Foroud T, Cloninger CR et al (2000) Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am J Med Genet 90(4):299-302
7. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P et al (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263(15):2055-2060
8. Cardenas L, Tremblay LK, Naranjo CA, Herrmann N, Zack M, Busto UE (2002) Brain reward system activity in major depression and comorbid nicotine dependence. J Pharmacol Exp Ther 302(3):1265-1271
9. Carmelli D, Swan GE, Robinette D, Fabsitz R (1992) Genetic influence on smoking-a study of male twins. N Engl J Med 327(12):829-833
10. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D (1996) The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 6(1):73-79
11. Fagerstrom KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3(3-4):235-241
12. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H et al (1989) The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45(5):778-785
13. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86(9):1119-1127
14. Hudmon KS (2005) Validity of retrospective assessments of tobacco dependence: a preliminary report. Addict Behav 30(3):613-617
15. Hudmon KS, Honn SE, Jiang H, Chamberlain RM, Xiang W, Ferry G et al (1997) Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev 6(8):565-571
16. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P et al (1999) Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4(3):290-296
17. Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B et al (1999) Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 18(1):14-20
18. Li MD, Cheng R, Ma JZ, Swan GE (2003) A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98(1):23-31
19. Li MD, Ma JZ, Beuten J (2004) Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet 66(5):382-392
20. Munafo M, Clark T, Johnstone E, Murphy M, Walton R (2004) The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 6(4):583-597
21. Munafo M, Timpson NJ, David SP, Ebrahim S, Lawlor DA (2009) Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res 11(1):64-76
22. Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23(6):540-545
23. Noble EP (2000) Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 15(2):79-89
24. Noble EP, Blum K, Khalsa ME, Ritchie T, Montgomery A, Wood RC et al (1993) Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 33(3):271-285
25. Noble EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ et al (1994) D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses 42(4):257-260
26. Osler M, Holst C, Prescott E, Sorensen TI (2001) Influence of genes and family environment on adult smoking behavior assessed in an adoption study. Genet Epidemiol 21(3):193-200
27. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK et al (1998) The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3(3):256-260
28. Pomerleau OF (1992) Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Am J Med 93(1A):2S-7S
29. Robinson JD, Lam CY, Minnix JA, Wetter DW, Tomlinson GE, Minna JD et al (2007) The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. Pharmacogenomics J 7(4):266-274
30. Services U. S. D. o. H. a. H (1988) The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. from http://www.cdc.gov. tobacco.sgr-1988.htm
31. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D et al (1992) Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 49(9):723-727
32. Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM et al (1998) Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 90(5):358-363
33. Swan GE, Hudmon KS, Khroyan TV (2003) Tobacco dependence. In: Nezu AM, Nezu CM, Gellaer PA (eds). Health psychology, volume 9 of the handbook of psychology, Editor-in-chief, Weiner IB. Wiley, New York
34. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK et al (1997) D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7(6):479-484
35. Weir B (1990) Genetic data analysis. Sinauer Associations, Sunderland
36. Wise RA (1987) The role of reward pathways in the development of drug dependence. Pharmacol Ther 35(1-2):227-263
37. Wise RA (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51(1-2):13-22
38. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191-225
39. Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR (2000) D2 dopamine receptor gene polymorphisms among African- Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev 9(10):1021-1026